D-Erythro-dihydrosphingosine
D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity.
Product Specifications
CAS Number
764-22-7
Product Name Alternative
Sphinganine (d18:0)
UNSPSC
12352211
Hazard Statement
H302, H315, H319
Target
Endogenous Metabolite; Phospholipase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/D-Erythro-dihydrosphingosine.html
Purity
99.55
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : 50 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO
Molecular Formula
C18H39NO2
Molecular Weight
301.51
Precautions
H302, H315, H319
References & Citations
[1]Nakamura H, et al. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004 Jan 19;484 (1) :9-17.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040916-500 1x 500 µL
Mucin 6 (MUC6) (MUC6/916), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050485-500 1x 500 µL
ODC-1 (Ornithine Decarboxylase-1) (ODC1/485), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 